LEPR and ovarian carcinoma: LEPR was found to be overexpressed in epithelial ovarian cancer indicating poor progression-free survival (Uddin et al., 2009) and its somatic mutation was found to increase the susceptibility to hepatocarcinogenesis (Ikeda et al., 2014).